Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis

AIDS

Volumn 13, Issue 1, 1999, Pages 1-22

  Brach Werner, Ruth ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Astrocytes; Brain; HIV 1 neuropathogenesis; Nef; Rev; Tat; Virus reservoirs

Indexed keywords

CD4 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; MEMBRANE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEF PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS RNA; ZIDOVUDINE;

ASTROCYTE; ASTROCYTOMA; CELL CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM; NEURONS;

EID: 0032989672     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00003     Document Type: Review

References (216)

1. 1. Gray F, Scaravilli F, Everall I, et al.: Neuropathology of early HIV-1 infection. Brain Pathol 1996, 6:1-15.
2. 2. An SF, Giometto B, Scaravilli F: HIV-1 DNA in brains in AIDS and pre-AIDS: Correlation with the stage of disease. Ann Neurul 1996, 40:611-617.
3. 3. Davis LE, Hjelle BL, Miller VE, et al.: Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992, 42:1736-1739.
4. 4. Palmer DL, Hjelle BL, Wiley CA, et al.: HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am J Med 1994, 97:289-295.
5. 5. Smith MO, Heyes MP, Lackner AA: Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus. Lab Invest 1995, 72:47-558.
6. 6. Hughes ES, Bell JE, Simmonds P: Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17(gag) and env genes. J Virol 1997, 71:1272-1280.
7. 7. Epstein LG, Kuiken C, Blumberg BM, et al.: HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 1991, 180:583-590.
8. 8. Keys B, Karis J, Fadeel B, et al.: V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 1993, 196:475-483.
9. 9. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman DD: In vivo compartimentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997, 71:2059-2071.
10. 10. Di Stefano M, Gray F, Leitner T, Chiodi F: Analysis of env V3 sequences from HIV-1-infected brain indicates restrained virus expression throughout the disease. J Med Virol 1996, 49:41-48.
11. 11. Cheng-Mayer C, Weiss C, Seto D, Levy JA: Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Natl Acad Sci USA 1989, 86:8575-8579.
12. 12. Chiodi F, Valentin A, Keys B, et al.: Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid. Virology 1989, 173:178-187.
13. 13. Johnson RT, Glass JD, McArthur JC, Chesebro BW: Quantitation of human immunodeficiency virus in brain of demented and nondemented patients with aquired immunodeficiency syndrome. Ann Neurol 1996, 39:392-395.
14. 14. Sinclair E, Gray F, Ciardi A, Scaravilli F: Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 1994, 53:43-50.
15. 15. Bell JE, Busuttil A, Ironside JW, et al.: Human immunodeficiency virus and the brain - investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993, 168:818-824.
16. 16. Schmid P, Conrad A, Syndulko K, et al.: Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1994, 7:777-788.
17. 17. Shaw GM, Harper ME, Hahn BH, et al.: HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985, 227:177-182.
18. 18. Bockstahler LE, Werner T, Festl H, et al.: Distribution of HIV genomic DNA in brains of AIDS patients. Clin Diag Virol 1995, 3:61-72.
19. 19. Fujimura RK, Goodkin K, Petito CK, et al.: HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J AIDS Hum Retrovirol 1997, 16:146-152.
20. 20. Fujimura RK, Shapshak P, Feaster D, Epler M, Goodkin K: A rapid method for comparative quantitative polymerase chain reaction of HIV-1 proviral DNA extracted from cryopreserved brain tissues. J Virol Methods 1997, 67:177-187.
21. 21. Dubois-Dalcq M, Altmeyer R, Chiron M, Wilt S: HIV interaction with cells of the nervous system. Curr Opin Neurobiol 1995, 5:647-655.
22. 22. Bell JE, Donaldson YK, Lowrie S, et al.: Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996, 10:493-499.
23. 23. Kolson DL, Pomerantz RJ: AIDS dementia and HIV-1 induced neurotoxicity: Possible pathogenic associations and mechanisms. J Biomed Sci 1996, 3:389-414.
24. 24. Glass JD, Johnson RT: Human immunodeficiency virus and the brain. Ann Rev Neurosci 1996, 19:1-26.
25. 25. Glass JD, Fedor H, Wesselingh SL, Mcarthur JC: Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995, 38:755-762.
26. 26. Portegies P: HIV-1, the brain, and combination therapy. Lancet 1995, 346:1244-1245.
27. 27. Bacellar H, Munoz A, Miller EN, et al.: Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS cohort study, 1985-1992. Neurology 1994, 44:1892-1900.
28. 28. Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B: Central nervous sytem as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir [letter]. AIDS 1997, 11:1302-1303.
29. 29. Epstein LG, Sharer LR, Cho E-S, Myenhofer M, Navia BA, Price RVV: HTLV-lll/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Research 1984/5, 1:447-454.
30. 30. Meyenhofer MF, Epstein LG, Cho ES, Sharer LR: Ultrastructural morphology and intracellular production of human immunodeficiency virus (HIV) in brain. J Neuropathol Exp Neurol 1987, 46:474-484.
31. 31. Nuovo GJ, Gallery F, MacConnell P, Braun A: In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol 1994, 144:659-666.
32. 32. Saito Y, Sharer LR, Epstein LG, et al.: Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994, 44:474-481.
33. 33. Tornatore C, Chandra R, Berger JR, Major EO: HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994, 44:481-487.
34. 34. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD: Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996, 39:705-711.
35. 35. Vazeux R, Brousse N, Jarry A, et al: AIDS subacute encephalitis. Am J Pathol 1987, 126:403-410.
36. 36. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho E-S, Price RW: HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987, 21:490-496.
37. 37. Wiley CA , Schrier RD, Nelson JA, et al.: Cellular localisation of human immunodeficiency virus infection within the brains of aquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986, 83:7089-7093.
38. 38. Wiley CA, Nelson JA: Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol 1988, 136:73-81.
39. 39. Kure K, Lyman WD, Weidenheim KM, Dickson DW: Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 1990, 136:1085-1092.
40. 40. Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO: Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev 1993, 6:339-366.
41. 41. Koenig S, Gendelmann HE, Orenstein JM, et al.: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233:1089-1093.
42. 42. Bagasra O, Lavi E, Bobroski L, et al.: Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996, 10:573-585.
43. 43. Ranki A, Nyberg M, Ovod V, et al.: Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995, 9:1001-1008.
44. 44. Nuovo GJ, Alfieri ML: AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 1996, 2:358-366.
45. 45. Brannagan TH, Nuovo GJ, Hays AP, Latov N: Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization. Ann Neurol 1997, 42:368-372.
46. 46. Gyorkey F, Melnick JL, Gyorkey P: Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis 1987, 155:870-876.
47. 47. Levy JA, Evans L, Cheng-Mayer C, et al.: The biological and molecular properties of the AIDS-associated retrovirus that affect antiviral therapy. Ann Imt Pasteur 1987, 138:101-111.
48. 48. Ensoli F, Wang H, Fiorelli V, et al.: HIV-1 infection and the developing nervous system: lineage-specific regulation of viral gene expression and replication in distinct neuronal precursors. J Neurovirol 1997, 3:290-298.
49. 49. Harouse JM, Gonzalez-Scarano F: Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates. J Virol 1996, 70:7290-7294.
50. 50. Shapshak P, Sun NCJ, Resnick L, et al.: HIV-1 propagates in human neuroblastoma cells. J Acquir Immune Defic Syndr 1991, 4:228-237.
51. 51. Mizrachi Y, Rodriguez I, Sweetnam PM, Rubinstein A, Volsky SJ: HIV type I infection of human cortical neuronal cells: enhancement by select neuronal growth factors. AIDS Res Hum Retrovirol 1994, 10:1593-1596.
52. 52. Li XL, Moudgil T, Vinters HV, Ho DD: CD-4 independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J Virol 1990, 64:1383-1387.
53. 53. Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, Gonzalez-Scarano F: HIV-1 infection of cultured human adult oligodendrocytes. Virology 1996, 17:211-219.
54. 54. Harouse JM, Wroblewska Z, Laughlin MA, Hickey WF, Schonwetter BS, Gonzalez-Scarano F: Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol 1989, 25:406-411.
55. 55. Poland SD, Rice GPA, Dekaban GA: HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J AIDS Hum Retrovirol 1995, 8:437-445.
56. 56. Moses AV, Bloom FE, Pauza CD, Nelson JA: Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 1993, 90:10474-10478.
57. 57. Brack-Werner R, Kleinschmidt A, Ludvigsen A, et al.: Infection of human brain cells by HIV-1:restricted virus production in chronically infected human glial cell lines. AIDS 1992, 6:273-285.
58. 58. Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger-Hodges MJ, Volsky DJ: Persistant productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol 1987, 61:3774-3782.
59. 59. Harouse JM, Bhat S, Spitalnik SL, et al.: Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991, 253:320-323.
60. 60. Dewhurst S, Bresser J, Stevenson M, Sakai K, Evinger-Hodges MJ, Volsky D: Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). FEBS Lett 1987, 213:138-143.
61. 61. Harouse JM, Kunsch C, Harlte HT, et al.: CD4-independent infection of human neuronal cells by human immunodeficiency virus type 1. J Virol 1989, 63:2527-2533.
62. 62. Harouse JM, Laughlin MA, Pletcher C, Friedman HM, Gonzalez-Scarano F: Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway. J Leukocyte Biol 1991, 49:605-609.
63. 63. Chiodi F, Fuerstenberg S, Gidlund M, Asjö B, Fenyö EM: Infection of brain-derived cells with the human immunodeficiency virus. J Virol 1987, 61:1244-1247.
64. 64. Keys B, Albert J, Kövamees J, Chiodi F: Brain-derived cells can be infected with HIV isolates derived from both blood and brain. Virology 1991, 183:834-839.
65. 65. Clapham PR, Weber JN, Whitby D, et al.: Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature 1989, 337:368-370.
66. 66. Weber J, Clapham P, McKeating J, Stratton M, Robey E, Weiss R: Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 receptor. J Gen Virol 1989, 70:2653-2660.
67. 67. Chesebro B, Buller R, Portis J, Wehrly K: Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol 1990, 64:215-221.
68. 68. McKnight A, Weiss RA, Shotton C, Takeuchi Y, Hoshino H, Clapham PR: Change in tropism upon immune escape by human immunodeficiency virus. J Virol 1995, 69:3167-3170.
69. 69. Cheng-Mayer C, Rutka JT, Rosenblum ML, McHugh T, Stites DP, Levy JA: Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci USA 1987, 84:3526-3530.
70. 70. Volsky B, Sakai K, Reddy MM, Volsky DJ: A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation. Virology 1992, 186:303-308.
71. 71. Ensoli F, Ensoli B, Thiele CJ: HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype - Effects of nerve growth factor. Virology 1994, 200:668-676.
72. 72. Stavrou D, Mehraein P, Mellert W, et al.: Evaluation of intracerebral lesions in patients with acquired immunodeficiency syndrome: neuropatholgical findings and experimental data. Neuropathol Appl Neurobiol 1989, 15:207-222.
73. 73. Dewhurst S, Stevenson M, Volsky DJ: Expression of the T4 molecule (AIDS virus receptor) by human brain-derived cells. FEBS Lett 1987, 213:133-137.
74. 74. Kozlowski MR, Sandler P, Lin PF, Watson A: Brain-derived cells contain a specific binding site for gp120 which is not the CD4 antigen. Brain Res 1991, 553:300-304.
75. 75. Bhat S, Mettus RV, Reddy EP, et al.: The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Hum Retrovirol 1993, 9:175-181.
76. 76. Bhat S, Spitalnik SL, Gonzalez-Scarano F, Silberberg DH: Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type-1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991, 88:7131-7134.
77. 77. Schneider-Schaulies J, Schneider-Schaulies S, Brinkmann R, et al.: HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology 1992, 191:765-772.
78. 78. Kunsch C, Wigdahl B: Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells. Virology 1939, 173:715-722.
79. 79. Kunsch C, Hartle HT , Wigdahl B: Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope. J Virol 1989, 63:5054-5061.
80. 80. Wigdahl B, Guyton RA, Sarin PS: Human immunodeficiency virus infection of the developing nervous system. Virology 1987, 159:440-445.
81. 81. Hatch WC, Pousada E, Losev L, Rashbaum WK, Lyman WD: Neural cell targets of human immunodeficiency virus type 1 in human fetal organotypic cultures. AIDS Res Hum Retrovirol 1994, 10:1597-1607.
82. 82. Hao HN, Chiu FC, Losev L, Weidenheim KM, Rashbaum WK, Lyman WD: HIV infection of human fetal neural cells is mediated by gp120 binding to cell membrane-associated molecule that is not CD4 nor galactocerebroside. Brain Res 1997, 764:149-157.
83. 83. Tornatore C, Nath A, Amemiya K, Major EO: Persistent human immunodeficiency virus type-1 infection in human fetal glial cells reactivated by T cell factor(s) or by the cytokines tumor necrosis factor-alpha and interleukin-1-beta. J Virol 1991, 65:6094-6100.
84. 84. Nath A, Hartloper VH, Furer M, Fowko KR: Infection of human fetal cells with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 1995, 54:320-330.
85. 85. Christofinis C, Papadaki L, Sattentau Q, Ferns RB, Tedder R: HIV replicates in cultured human brain cells. AIDS 1987, 1:229-234.
86. 86. Ma MH, Geiger JD, Nath A: Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes. J Virol 1994, 68:6824-6828.
87. 87. Fiala M, Rhodes RH, Shapshak P, et al.: Regulation of HIV-1 infection in astrocytes: expression of Nef, TNF-alpha and IL-6 is enhanced in coculture of astrocytes with macrophages. J Neurovirol 1996, 2:158-166.
88. 88. Brengel-Pesce K, Innocenti-Francillard P, Morand P, Chanzy B, Seigneurin JM: Transient infection of astrocytes with HIV-1 primary isolates derived from patients with and without AIDS dementia complex. J Neurovirol 1997, 3:449-454.
89. 89. McCarthy M, He J, Wood C: HIV-1 strain-associated variability in infection of primary neuroglia. J Neurovirol 1998, 4:80-89.
90. 90. Canki M, Potash MJ, Bentsman G, et al.: Isolation and long-term culture of primary ocular human immunodeficiency virus type 1 isolates in primary astrocytes. J Neurovirol 1997, 3:10-15.
91. 91. Broder CC, Collman RG: Chemokine receptors and HIV. J Leukocyte Biol 1997, 62:20-29.
92. 92. Luster AD: Chemokines - Chemotactic cytokines that mediate inflammation. New Engl J Med 1998, 338:436-445.
93. 93. Hoffman TL, Doms RW: Chemokines and coreceptors in HIV/SIV-host interactions. AIDS 1998 12(suppl A):S17-S26.
94. 94. Littman DR: Chemokine receptors: Keys to AIDS pathogenesis? Cell 1998, 93:677-680.
95. 95. He JL, Chen YZ, Farzan M, et al.: CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 1997, 385:645-649.
96. 96. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ: Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 1997, 151:1341-1351.
97. 97. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987, 236:819-822.
98. 98. Ghorpade A, Nukuna A, Che M, et al.: Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 1998, 72:3340-3350.
99. 99. Power C, McArthur JC, Johnson RT, et al.: Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Topics Microbiol Immunol 1995, 202:89-104.
100. 100. Mankowski JL, Flaherty MT, Spelman JP, et al.: Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 1997, 71:6055-6060.
101. 101. Zink MC, Spelman JP, Bedno Robinson R, Clements JE: SIV infection of macaques - modeling the progression to AIDS dementia. J Neurovirol 1998, 4:249-259.
102. 102. Levy JA: HIV and the Pathogenesis of AIDS. Washington: American Society for Microbiology; 1998.
103. 103. Srinivasan A, Dorselt D, York D, Bohan C, Anand R: Human immunodeficiency virus replication in human brain cells. Arch Virol 1998, 98:135-141.
104. 104. Neumann M, Felber BK, Kleinschmidt A, et al.: Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1995, 69:2159-2167.
105. 105. Kleinschmidt A, Neumann M, Moller C, Erfle V, Brack-Werner R: Restricted expression of HIV1 in human astrocytes: Molecular basis for viral persistence in the CNS. Res Virol 1994, 145:147-153.
106. 106. Tornatore C, Meyers K, Atwood W, Conant K, Major E: Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994, 68:93-102.
107. 107. Atwood WJ, Tornatore C: Stimulation of HIV Type 1 gene expression and induction of NF-kappaB (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. AIDS Res Hum Retrovirol 1994, 10:1207-1211.
108. 108. Moreno TN, Fortunate EA, Hsia K, Spector SA, Spector DH: A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells. J Virol 1997, 71:3693-3701.
109. 109. Ludvigsen A, Werner T, Gimbel W, Erfle V, Brack-Werner R: Down-modulation of HIV-1 LTR activity by an extra-LTR nef gene fragment. Virology 1996, 216:245-251.
110. 110. Niikura M, Dornadalu G, Zhang H, et al.: Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type 1 replication in an astrocytic glial cell. Oncogene 1996, 13:313-322.
111. 111. Shahabuddin M, Bentsman G, Volsky B, Rodriguez I, Volsky DJ: A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. J Virol 1996, 70:7992-8002.
112. 112. Taylor JP, Pomerantz R, Bagasra O, et al.: TAR-Independent transactivation by Tat in cells derived from the CNS - a novel mechanism of HIV-1 gene regulation. EMBO J 1992, 11:3395-3403.
113. 113. Taylor JP, Pomerantz RJ, Raj GV, et al.: Central nervous system-derived cells express a kappa β-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. J Virol 1994, 68:3971-3981.
114. 114. Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB: Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Virology 1997, 235:48-64.
115. 115. Rutka JT, Murakami M, Dirks PB, et al.: Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 1997, 87:420-430.
116. nd Edn. New York: Elsevier; 1991.
117. 117. Miller RH, Raff MC: Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci 1984, 4:585-592.
118. 118. Raff MC: Glial cell diversification in the rat optic nerve. Science 1989, 243:1450-1455.
119. 119. Kimelberg HK: Receptors on astrocytes - what possible functions? Neurochem Int 1995, 26:27-40.
120. 120. Barres BA, Chun LL, Corey DP: Ion channels in vertebrate glia. Annu Rev Neurosci 1990, 13:441-474.
121. 121. Berry M, Butt AM: Structure and function of glia in the central nervous sytem. In Greenfield's Neuropathology, 6th Edn. Edited by Graham DI, Lantos PL. London: Arnold; 1997, 2:63-83.
122. 122. Labourdette G, Sensenbrenner M: Growth factors and their receptors in the central nervous system. In Neuroglia. Edited by Kettenmann H, Ransom BR. New York: Oxford Unviersity Press; 1995, 30:441-459.
123. 123. Pfrieger FW, Barres BA: New views on synapse-glia interactions. Curr Opin Neurobiol 1996, 6:615-621.
124. 124. Pellerin L, Stolz M, Sorg O, Martin JL, Deschepper CF, Magistretti PJ: Regulation of energy metabolism by neurotransmitters in astrocytes in primary culture and in an immortalized cell line. Glia 1997, 21:74-83.
125. 125. Wilkin GP, Marriott DR, Cholewinski AJ: Astrocyte heterogeneity. TINS 1990, 13:43-46.
126. 126. Kreutzberg GW, Blakemore WF, Graeber MB: Cellular pathology of the central nervous system. In Greenfield's Neuropathology, 6th Edn. Edited by Graham DI, Lantos PL. London: Arnold; 1997, 2:85-151.
127. 127. Eddleston M, Mucke L: Molecular profile of reactive astrocytes - implications for their role in neurological disease. Neuroscience 1993, 54:15-36.
128. 128. Ridet JL, Malhotra SK, Privat A, Gage FH: Reactive astrocytes: cellular and molecular cues to biological function. TINS 1997, 20:570-577.
129. 129. Prehn JH, Bindokas VP, Marcuccilli CJ, Krajewski S, Reed JC, Miller C: Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming grwoth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci USA 1994, 91:12599-12603.
130. 130. Meucci O, Miller RJ: gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta 1. J Neurosci 16:4080-4088.
131. 131. Scorziello A, Florio T, Bajetto A, Thellung S, Schettini G: TGF-beta 1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic death. J Neurosci Res 1997, 49:600-607.
132. 132. Da Cunha A, Jefferson JJ, Tyor WR, Galss JD, Jannotta FS, Vitkovic L: Control of astrocytosis by interleukin-1 and transforming growth factor-beta 1 in human brain. Brain Res 631:39-45.
133. 133. Stanley LC, Mrak RE, Woody RC, et al.: Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 1994, 53:231-238.
134. 134. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175.
135. 135. Sharer LR. Pathology of HIV-1 infection of the central nervous system - a review. J Neuropathol Exp Neurol 1992, 51:3-11.
136. 136. Vitkovic L, da Cunha A: Role for astrocytosis in HIV-1 associated dementia. Curr Topics Microbiol Immunol 1995, 202:105-116.
137. 137. Bell JE: The neuropathology of adult HIV infection. Rev Neurol (Paris) 1998, 154:1-13.
138. 138. Williams KC, Hickey WF: Traffic of lymphocytes into the CNS during inflammation and HIV infection. J Neurol AIDS 1996, 1:31-55.
139. 139. Nottet HS, Persidsky Y, Sasseville VG, et al.: Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996, 156:1284-1295.
140. 140. Persidsky Y, Stins M, Way D, et al.: A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997, 158:3499-3510.
141. 141. Kibayashi K, Mastri AR, Hirsch CS: Neuropathology of human immundeficiency virus infection at different disease stages. Hum Pathol 1996, 27:637-642.
142. 142. Smith TW, DeGirolami U, Henin D, Bolgert F, Hauw JJ: Human immunodeficiency virus (HIV) leukoencephalopathy and the mocrocirculation. J Neuropathol Exp Neurol 1990, 49:357-370.
143. 143. Ward JM, O'Leary TJ, Baskin GB, et al.: Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 1987, 127:199-205.
144. 144. Edinger AL, Mankowski JL, Doranz BJ, et al.: CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 1997, 94:14742-14747.
145. 145. Moses AV, Nelson JA: HIV infection of human brain capillary endothelial cells - Implications for AIDS dementia. Adv Neuroimmunol 1994, 4:239-247.
146. 146. Moses AV, Stenglein SG, Strussenberg JG, Wehrly K, Chesebro B, Nelson JA: Sequences regulating tropism of human immunodeficiency virus type 1 for brain capillary endothelial cells map to a unique region on the viral genome. J Virol 1996, 70:3401-3406.
147. 147. Owens RJ, Dubay JW, Hunter E, Compans RW: Human Immunodeficiency Virus Envelope Protein Determines the Site of Virus Release in Polarized Epithelial Cells. Proc Natl Acad Sci USA 1991, 88:3987-3991.
148. 148. Bomsel M: Transcytosis of infectious human immunodeficiency across a tighthuman epithelial cell line barrier. Nature Med 1997, 3:42-47.
149. 149. Chiodi F, Keys B, Albert J, et al.: Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992, 30:1768-1771.
150. 150. Cheng-Meyer C, Levy JA: Human immunodeficiency virus infection of the CNS: characterization of 'neurotropic' strains. Curr Topics Microbiol Immunol 1990, 160:145-156.
151. 151. Hurwitz AA, Berman JW, Lyman WD: The role of the blood-brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol 1994, 4:249-256.
152. 152. Rosenman SJ, Shrikant P, Dubb L, Benveniste EN, Ransohoff RM: Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol 1995, 15:1888-1899.
153. 153. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC: Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 1997, 175:478-481.
154. 154. Conant K, Garzino-Demo A, Nath A, et al.: Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998, 95:3117-3121.
155. 155. Merrill JE, Benveniste EN: Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurol Sci 1996, 19:331-338.
156. 156. Volsky DJ, Bencheikh M, Canki M, et al.: HIV-1 infection impairs glutamate uptake by human fetal astrocytes: potential mechanism for AIDS dementia. Neuroscience of HIV Infection. Chicago, June 1998. J Neurovirol 1998, 4:369.
157. 157. Yu N, Billaud JN, Phillips TR: Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci USA 1998, 95:2624-2629.
158. 158. Chao CC, Hu S, Peterson PK: Glia: the not so innocent bystanders. J Neurovirol 1996, 2:234-239.
159. 159. Lipton SA: Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol 1996, 6:507-517.
160. 160. Dewhurst S, Gelbard HA, Fine SM: Neuropathogenesis of AIDS. Mol Med Today 1996, January: 16-23.
161. 161. Nath A, Geiger J: Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Progress in Neurobiol 1998, 54:19-33.
162. 162. Aloisi F, Ceccherini-Silberstein F, Levi G: Cytokine and growth factor synthesis in human astrocytes. In Molecular Signaling and Regulation in Glial Cells: A Key to Remyelination and Functional Repair. Edited by Jeserich G, Althaus HH, Richter-Landsberg C, Heumann R. Berlin Heidelberg: Springer Verlag; 1997:11-19.
163. 163. Benveniste EN: Cytokine production. In Neuroglia. Edited by Kettenmann H, Ransom BR. New York: Oxford Unviersity Press; 1995, 46:700-713.
164. 164. Lokensgard JR, Gekker G, Ehrlich LC, Hu S, Chao CC, Peterson PK: Proinflammalory cytokines inhibit HIV-1 (SF162) expression in acutely infected human brain cell cultures. J Immunol 1997, 158:2449-2455.
165. 165. Wahl SM, Allen JB, McCartney-Francis N, et al.: Macrophage and astrocyte-derived transforming growth factor α as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991, 173:981-991.
166. 166. Johnson MD, Gold LI: Distribution of transforming growth factor-beta isoforms in human immunodeficiency virus-1 encephalitis. Hum Pathol 1996, 27:643-649.
167. 167. Schmidt-Mayerova H, Nottet HS, Nuovo G, et al.: Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996, 23:700-704.
168. 168. Vitkovic L, Chatham JJ, Dacunha A: Distinct expressions of three cytokines by IL-1-stimulated astrocytes in vitro and in AIDS brain. Brain Behav Immunol 1995, 9:378-388.
169. 169. Rho MB, Wesselingh S, Glass JD, et al.: A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav Immunol 1995, 9:366-377.
170. 170. Seilhean D, Kobayashi K, He Y, et al.: Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol (Berlin) 1997, 93:508-517.
171. 171. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW, Griffin DE: Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol 1997, 74:1-8.
172. 172. Tyor WR, Glass JD, Griffin JW, et al.: Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992, 31:349-360.
173. 173. Aloisi F, Borsellino G, Car, A, et al.: Cytokine regulation of astrocyte function: in vitro studies using cells from the human brain. Int J Dev Neurosci 1995, 13:265-274.
174. 174. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC: Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994, 16:152-161.
175. 175. Hu J, Ferreira A, Van Eldik LJ: S100 beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 1997, 69:2294-2301.
176. 176. Hernandez M, Bayon Y, Sanchez Crespo M, Nieto ML: Thrombin produces phosphorylation of cytosolic phospholipase A2 by a mitogen-activated protein kinase kinase-independent mechanism in the human astrocytoma cell line 1321N1. Biochem J 1997, 328:263-269.
177. 177. Tournier C, Thomas G, Pierre J, Jarquemin C, Pierre M, Saunier B: Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase). Eur J Biochem 1997, 244:587-595.
178. 178. Kingsman SM, Kingsman AJ: The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem 1996, 240:491-507.
179. 179. Luciw PA: Human immunodeficiency viruses and their replication. In Virology, Vol. 2, 3rd Edn. Edited by Fields BN, Knipe DM, Howley PM. Philadelphia: Lipincott-Raven Publishers; 1996:1881-1952.
180. 180. Ensoli B, Buonaguro L, Barillari G, et al.: Release, uptake, and effects of extracellular human immunodeficiency virus type-1 tat protein on cell growth and viral transactivation. J Virol 1993, 67:277-287.
181. 181. Ramazzolti E, Vignoli M, Re MC, Furlini G, La Placa M: Enhanced nuclear factor-κ B activation induced by tumor necrosis factor-α in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein. AIDS 1996, 10:455-461.
182. 182. Vives E, Brodin P, Lebleu B: A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumultes in the cell nucleus. J Biol Chem 1997, 272:16010-16017.
183. 183. Kolson DL, Collman R, Hrin R, et al.: Human immunodeficiency virus type 1 tat activity in human neuronal cells: uptake and trans-activation. J Gen Virol 1994, 73:1927-1934.
184. 184. Ma M, Nath A: Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 1997, 71:2495-2499.
185. 185. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM: Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 1994, 54:19-28.
186. 186. Taylor JP, Cupp C, Diaz A, et al.: Activation of expression of genes coding for extracellular matrix proteins in Tat-Producing glioblastoma cells. Proc Natl Acad Sci USA 1992, 89:9617-9621.
187. 187. Yang L, Morris GF, Wang Z, Bohan Morris C: Repression of tumor necrosis factor-beta expression by the human immunodeficiency virus type-1 Tat protein in central nervous system-derived glial cells. Virus Res 1997, 50:195-203.
188. 188. Chen P, Mayne M, Power C, Nath A: The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem 1997, 272:22385-22388.
189. 189. Cupp C, Taylor JP, Khalili K, Amini S: Evidence for stimulation of the transforming growth factor beta-1 promoter by HIV-1 tat in cells derived from CNS. Oncogene 1993, 8:2231-2236.
190. 190. Menegon A, Leoni C, Benfati F, Valtorta F: Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem Biophys Res Comm 1997, 238:800-805.
191. 191. Conant K, Ma MH, Nath A, Major EO: Extracellular human immunodeficiencyvirus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 1996, 70:1384-1389.
192. 192. Kolson DL, Buchhalter J, Collman R, et al.: HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures - rgd sequence dependence. AIDS Res Hum Retrovirol 1993, 9:677-685.
193. 193. Sabatier J-M, Vives E, Mabrouk K, et al.: Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. J Virol 1991, 65:961-967.
194. 194. Nath A, Psooy K, Martin C, et al.: Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996, 70:1475-1480.
195. 195. Cheng J, Nath A, Knudsen B, et al.: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 1998, 82:97-106.
196. 196. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nath A: Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995, 37:373-380.
197. 197. Hayman M, Arbuthnott G, Harkiss G, et al.: Neurotoxicity of peptide analogues of the transactivating protein Tat from Maedi-Visna virus and human immunodeficiency virus. Neurosci 1993, 53:1-6.
198. 198. Philippon V, Vellutini C, Gambarelli D, et al.: The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 1994, 205:519-529.
199. 199. New DR, Ma MH, Epstein LG, Nath A, Gelbard HA: Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997, 3:168-173.
200. 200. Mabrouk K, Van Rietschoten J, Vives E, Darbon H, Rochat H, Sabatier JM: Lethal neurotoxicity in mice of the basic domains of HIV and SIV Rev proteins - study of these regions by circular dichroism. FEBS Lett 1991, 289:13-17.
201. 201. Harris M: From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. J Gen Virol 1996, 77:2379-2392.
202. 202. Romero IA, Teixeira A, Strosberg AD, Cazaubon S, Couraud PO: The HIV-1 Nef protein inhibits extracellular signal-regulated kinase-dependent DNA synthesis in a human astrocytic cell line. J Neurochem 1998, 70:778-785.
203. 203. Richard A, Robichaud G, Lapointe R, Bourgoin S, Darveau A, Poulin L: Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumor necrosis factor-α in human glial cells. AIDS 1997, 11:F1-F7.
204. 204. Werner T, Ferroni S, Saermark T, et al.: HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS 1991, 5:1301-1308.
205. 205. He JL, deCastro CM, Vandenbark GR, Busciglio J, Gabuzda D: Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protoOncogene. Proc Natl Acad Sci USA 1997, 94:3954-3959.
206. 206. Vitkovic L, Wood GP, Major EO, Fauci AS: Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. AIDS Res Hum Retroviruses 1991, 7:723-727.
207. 207. Genis P, Jett M, Bernton EW, et al.: Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-lnfected Macrophage-astroglia interactions - implications for the neuropathogenesis of HIV disease. J Exp Med 1992, 176:1703-1718.
208. 208. Dreyer EB, Lipton SA: The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 1995, 7:2502-2507.
209. 209. Fine SM, Angel RA, Perry SW, et al.: Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes - implications for pathogenesis of HIV-1 dementia. J Biol Chem 1996, 271:15303-15306.
210. 210. Nottet HSLM, Jett M, Flanagan CR: A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995, 154:3567-3581.
211. 211. Morgan RA: Gene therapy for HIV infection. Clin Exp Immunol 1997, 107(suppl 1):41-44.
212. 212. Williams RW, Herrup K: The control of neuron number. Annu Rev Neurosci 1988, 11:423-453.
213. 213. Gehrmann J, Matsumoto Y, Kreutzberg GW: Microglia: intrinsic immune effector cell of the brain. Brain Res Rev 1995, 20:269-287.
214. 214. Trepel F: Number and distribution of lymphocytes in man. A critical analysis. Win Wschr 1974, 52:511-515.
215. 215. Embretson J, Zupancic M, Beneke J, et al.: Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci USA 1993, 90:357-361.
216. 216. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ: Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. New Engl J Med 1992, 326:1385-1391.